UNLOCK THE POWER OF GENETICS
At Myriad Women’s Health, we believe in the power of human understanding. That's why we offer a personal and thoughtful genetic insights experience for providers and the women who rely on them.
Your Partner
in Patient Care
We provide transformative genetic insights that let you focus on what you do best, offering definitive results and support whenever you need it.
Cancer Risk Assessment
Starting a family
Myriad myRisk® Hereditary Cancer Test
Help patients get ahead of cancer with
our hereditary cancer test
Myriad Foresight® Carrier Screen
Identify couples at risk to pass down serious, prevalent, clinically-actionable inherited conditions
Learn moreMyriad PrequelTM Prenatal Screen
Get reliable results the first time with noninvasive prenatal screening
Learn moreWe're reimagining the future of genetics
50%
of hereditary cancers are non BRCA1/2
> Learn how to identify more patients at high risk for hereditary cancer76%
of couples took action after screening
> Learn how couples at-risk for serious conditions pursued alternative reproductive actions86%
of affected pregnancies no longer missed
> Learn how ECS detects more at-risk couples for serious conditionsWhy Genetic Screening and Testing?
All Patients Deserve Genetic Insights
At Myriad Women’s Health, you can count on us to do the heavy lifting in the moments that matter.
Together,
with Myriad Women's Health
References
- Hogan et al. Validation of an Expanded Carrier Screen that Optimizes Sensitivity via Full-Exon Sequencing and Panel-wide Copy Number Variant Identification. Clinical Chemistry 2018; doi:10.1373/clinchem.2018.286823
- Ghiossi, C.E., Goldberg, J.D., Haque, I.S. et al. J Genet Counsel (2017). https://doi.org/10.1007/s10897-017-0160-1.
- Norton, M. et al Cell free DNA analysis for noninvasive examination of trisomy. The New England Journal of Medicine April 2015; 372: 1589-1597.
- BRCA1/BRCA2 Frequency: Gabai-Kapara E, Lahad A, Kaufman B, et al. Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. Proc Natl Acad Sci U S A. 2014.